The 6-Minute Walk Test in Pulmonary Arterial Hypertension
- 1 September 2012
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 186 (5), 396-397
- https://doi.org/10.1164/rccm.201206-1137ed
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2011
- Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical TrialJournal of the American College of Cardiology, 2010
- Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation, 2009
- Ambrisentan for the Treatment of Pulmonary Arterial HypertensionCirculation, 2008
- Sildenafil Citrate Therapy for Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2005
- Inhaled Iloprost for Severe Pulmonary HypertensionThe New England Journal of Medicine, 2002
- Bosentan Therapy for Pulmonary Arterial HypertensionThe New England Journal of Medicine, 2002
- Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionThe New England Journal of Medicine, 1996